SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kobo Biotech - Quaterly Results

08 Nov 2021 Evaluate
The revenue for the September 2021 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended September 2021 is Rs. -18.64 millions as compared to Net Loss of Rs. -56.88 millions of corresponding quarter ended September 2020 Operating profit Margin for the quarter ended September 2021 improved to -6.99% as compared to -6.67% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.17 0.36 -52.78 0.36 19.54 -98.16
PBIDT -6.99 -6.67 4.80 -9.45 -12.32 -23.30 -27.53 -6.53 321.59
Interest 1.35 36.00 -96.25 1.35 72.40 -98.14 108.41 144.75 -25.11
PBDT -8.34 -42.67 -80.45 -10.80 -84.72 -87.25 -135.94 -151.28 -10.14
Depreciation 10.30 14.21 -27.52 23.81 28.27 -15.78 56.37 58.78 -4.10
PBT -18.64 -56.88 -67.23 -34.61 -112.99 -69.37 -192.31 -210.06 -8.45
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -18.64 -56.88 -67.23 -34.61 -112.99 -69.37 -192.31 -210.06 -8.45
Equity 238.25 238.25 0.00 238.25 238.25 0.00 238.25 238.25 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kobo Biotech Share Price

2.74 0.12 (4.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×